Koninklijke Philips (NYSE:PHG) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Koninklijke Philips (NYSE:PHG) has been given a consensus recommendation of “Moderate Buy” by the five brokerages that are currently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company.

PHG has been the subject of several recent research reports. StockNews.com upgraded Koninklijke Philips from a “hold” rating to a “buy” rating in a research report on Saturday. UBS Group upgraded Koninklijke Philips from a “neutral” rating to a “buy” rating in a report on Thursday, February 20th. Finally, BNP Paribas upgraded Koninklijke Philips from a “neutral” rating to an “outperform” rating in a report on Tuesday, February 25th.

Institutional Investors Weigh In On Koninklijke Philips

A number of large investors have recently bought and sold shares of the company. FMR LLC boosted its position in Koninklijke Philips by 0.6% in the third quarter. FMR LLC now owns 6,138,708 shares of the technology company’s stock valued at $200,859,000 after buying an additional 35,935 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in Koninklijke Philips by 2.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 4,290,051 shares of the technology company’s stock valued at $108,624,000 after buying an additional 85,994 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. boosted its position in Koninklijke Philips by 87.7% in the fourth quarter. Connor Clark & Lunn Investment Management Ltd. now owns 2,222,192 shares of the technology company’s stock valued at $56,266,000 after buying an additional 1,038,321 shares during the last quarter. Northern Trust Corp boosted its position in Koninklijke Philips by 36.6% in the fourth quarter. Northern Trust Corp now owns 1,608,749 shares of the technology company’s stock valued at $40,734,000 after buying an additional 430,757 shares during the last quarter. Finally, Causeway Capital Management LLC boosted its position in Koninklijke Philips by 24.0% in the 4th quarter. Causeway Capital Management LLC now owns 1,566,850 shares of the technology company’s stock worth $39,673,000 after purchasing an additional 303,428 shares in the last quarter. Hedge funds and other institutional investors own 13.67% of the company’s stock.

Koninklijke Philips Trading Up 1.9 %

Shares of PHG stock opened at $27.58 on Monday. Koninklijke Philips has a 12-month low of $19.10 and a 12-month high of $32.91. The company has a current ratio of 1.23, a quick ratio of 0.74 and a debt-to-equity ratio of 0.59. The stock’s 50-day moving average price is $26.51 and its 200-day moving average price is $27.97. The stock has a market capitalization of $25.93 billion, a price-to-earnings ratio of -32.84, a price-to-earnings-growth ratio of 0.82 and a beta of 0.78.

Koninklijke Philips (NYSE:PHG) last issued its earnings results on Wednesday, February 19th. The technology company reported $0.54 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by ($0.01). The firm had revenue of $5.38 billion during the quarter, compared to the consensus estimate of $5.10 billion. Koninklijke Philips had a positive return on equity of 10.85% and a negative net margin of 3.88%. Equities research analysts predict that Koninklijke Philips will post 1.63 EPS for the current fiscal year.

Koninklijke Philips Cuts Dividend

The firm also recently declared an annual dividend, which will be paid on Friday, June 6th. Stockholders of record on Tuesday, May 13th will be paid a dividend of $0.886 per share. The ex-dividend date of this dividend is Tuesday, May 13th. This represents a dividend yield of 2.9%. Koninklijke Philips’s payout ratio is -89.29%.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.